Paul McGee

Paul McGee has 27 years of working on CMC programmes from early development to commercial supply. His previous roles include Head of CMC at Heptares Therapeutics, Senior Director Chemical Development at Shire Pharmaceuticals, Site Head Aptuit and SVP, Chemical Development at Evotec.

Paul studied Chemistry at Oxford University and following completion of his studies, moved into industry in the early 1990’s, working for chemistry services-based organisations and leading operations involving 150 employees, delivering on >1000 projects. For the last 10 years Paul has been responsible for management of drug substance and drug product development programmes and supply of investigation medicinal products in a virtual environment employing external service providers for research, development and manufacture.